- Energizer Holdings to acquire feminine hygiene business from J&J Family of Consumer Cos.
- McMillon set to succeed Duke as Walmart CEO
- AmerisourceBergen reports Q4 results
- CVS Caremark's 'ability' and 'agility' a key focus of 2013 Analyst Day
- Walgreens expanding scope of retail pharmacy experience and services heading into fiscal 2014
NEW BRUNSWICK, N.J. — Johnson & Johnson on Wednesday announced that Alex Gorsky, currently worldwide chairman of medical devices and diagnostics, and Sheri McCoy, currently worldwide chairman of pharmaceuticals, have been appointed vice chairmen of the executive committee, joining William Weldon, J&J chairman and CEO, in an expanded Office of the Chairman.
Both appointments are effective Jan. 3.
“The changes are an appropriate step in furthering our long-term succession plans, and assuring talented, experienced leaders at all levels of the organization,” Weldon stated.
Gorsky, 50, will assume expanded responsibilities that include the medical device and diagnostics group, global supply chain, government affairs and policy, and the Johnson & Johnson Development Corp. McCoy, 52, will assume expanded responsibilities that include the pharmaceuticals group, consumer group, the corporate office of science and technology, and corporate affairs.
Other executive announcements include Jesse Wu, currently company group chairman of global markets organization in the consumer group, was named worldwide chairman of consumer and will report to McCoy. Joaquin Duato, formerly pharmaceuticals company group chairman of the Americas group, was named worldwide chairman of pharmaceuticals with responsibility for commercial businesses and operations. And Paul Stoffels, currently global head of pharmaceuticals research and development, was named worldwide chairman of pharmaceuticals with responsibility for research and development, business development and strategic development. Both Duato and Stoffels will report to McCoy.
Peter Fasolo, worldwide VP human resources, will join the executive committee and continue to focus on talent development and succession planning at all levels of the corporation.